<--- Back to Details
First PageDocument Content
Clinical medicine / Cancer / Medicine / Cancer treatments / Organofluorides / Angiogenesis inhibitors / Eli Lilly and Company / Bevacizumab / FOLFIRI / FOLFOXIRI / Chemotherapy regimen / Cetuximab
Date: 2016-07-02 18:03:03
Clinical medicine
Cancer
Medicine
Cancer treatments
Organofluorides
Angiogenesis inhibitors
Eli Lilly and Company
Bevacizumab
FOLFIRI
FOLFOXIRI
Chemotherapy regimen
Cetuximab

References [1] R. A. Adams, A. M. Meade, A. Madi, D. Fisher, E. Kay, S. Kenny, R. S. Kaplan, and T. S. Maughan. Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC

Add to Reading List

Source URL: www.toumiak.com

Download Document from Source Website

File Size: 351,52 KB

Share Document on Facebook

Similar Documents

CMTF005 - Food is Medicine - Checklist_Debranded

CMTF005 - Food is Medicine - Checklist_Debranded

DocID: 1xVMk - View Document

Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses Daniel Halperin† Thomas S. Heydt-Benjamin†

Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses Daniel Halperin† Thomas S. Heydt-Benjamin†

DocID: 1xVge - View Document

CMTF005 - Food is Medicine - Checklist_Debranded_with bleed

CMTF005 - Food is Medicine - Checklist_Debranded_with bleed

DocID: 1xUza - View Document

CMTF005 - Food is Medicine - Checklist_Debranded_edited

CMTF005 - Food is Medicine - Checklist_Debranded_edited

DocID: 1xTtU - View Document

PDF Document

DocID: 1xSqy - View Document